![Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence | SpringerLink Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12016-020-08794-6/MediaObjects/12016_2020_8794_Fig1_HTML.png)
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence | SpringerLink
H1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects – A Retrospective Survey Study
![Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria | Clinical and Translational Allergy | Full Text Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria | Clinical and Translational Allergy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13601-017-0141-3/MediaObjects/13601_2017_141_Fig2_HTML.gif)
Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria | Clinical and Translational Allergy | Full Text
![Intravenous Cetirizine Versus Intravenous Diphenhydramine for the Treatment of Acute Urticaria: A Phase III Randomized Controlled Noninferiority Trial - Annals of Emergency Medicine Intravenous Cetirizine Versus Intravenous Diphenhydramine for the Treatment of Acute Urticaria: A Phase III Randomized Controlled Noninferiority Trial - Annals of Emergency Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/224ce578-06fa-44f1-b9ba-147a088bea32/gr1_lrg.jpg)